Skip to content
Home/Companies/MedTech/IXI

IXI

MedTech·Finland·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns IXI?

IXI is a Finnish MedTech company, currently owned by byFounders since 2022 and Heartcore Capital.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Heartcore Capital
Most recent investor
Heartcore Capital
Heartcore Capital Fund IV · 2021 · VC
2 ownership periods · full history below

Key facts

HQFinland
SectorMedTech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by byFounders and Heartcore Capital since 2022.
Co-invest · 2 holders · 2022 · present
byFounders
byFoundersActive
2022 · present(4yr) · byFounders II · 2020 · VC
Heartcore Capital
Heartcore CapitalActive
2022 · present(4yr) · Heartcore Capital Fund IV · 2021 · VC

More from Heartcore Capital Fund IV

Other portfolio companies in the same fund.

Axana
Active
HealthTechUK· 2024
Byway
Active
HospitalityUK· 2024
Cula Technologies
Active
ClimateTechGermany· 2024
Skynopy
Active
Aerospace & DefenceFrance· 2024
Sunbeam
Active
Data & AnalyticsUK· 2024
Voyfai
Active
LogisticsGermany· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns IXI?

IXI is currently owned by byFounders and Heartcore Capital, through Heartcore Capital Fund IV, since 2022.

When did byFounders and 1 other acquire IXI?

byFounders and 1 other acquired IXI in 2022.

Who has owned IXI over time?

IXI has been through 2 private-equity ownership periods: byFounders · via byFounders II · since 2022; Heartcore Capital · via Heartcore Capital Fund IV · since 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue